(Q40393267)

20 September 2017

1 reference

title

Vasodilators in heart failure. Conclusions from V-HeFT II and rationale for V-HeFT III. (English)

1 reference

20 September 2017

0 references

Cohn JN

1

1 reference

20 September 2017

publication date

1 January 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

47 Suppl 4

1 reference

20 September 2017

page(s)

47-57; discussion 57-8

1 reference

Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure

20 September 2017

cites work

1 reference

12 December 2020

Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure

1 reference

12 December 2020

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

1 reference

12 December 2020

Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.

1 reference

12 December 2020

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

1 reference

12 December 2020

Prognosis of congestive heart failure and predictors of mortality

1 reference

12 December 2020

Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure

1 reference

12 December 2020

Treatment of refractory heart failure with infusion of nitroprusside.

1 reference

12 December 2020

Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo

1 reference

12 December 2020

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

1 reference

12 December 2020

Vasodilator therapy of cardiac failure: (first of two parts)

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure

1 reference

12 December 2020

Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure

1 reference

12 December 2020

Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure

1 reference

12 December 2020

Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure

1 reference

12 December 2020

Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside

1 reference

12 December 2020

Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective

1 reference

12 December 2020

Long-term therapy of heart failure with prazosin: a randomized double blind trial

1 reference

12 December 2020

Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Correlates and prognostic implication of exercise capacity in chronic congestive heart failure

1 reference

12 December 2020

Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation

1 reference

12 December 2020

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Regional and systemic metabolic effects of angiotensin-converting enzyme inhibition during exercise in patients with severe heart failure

1 reference

12 December 2020

Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Controlled trial of enalapril in congestive cardiac failure

1 reference

12 December 2020

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

1 reference

12 December 2020

10.2165/00003495-199400474-00008

Identifiers

DOI

0 references

1 reference